CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression

Overview of attention for article published in Frontiers in Pharmacology, July 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 5,856 followers.

New Research: CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression https://t.co/bvJJHpDtfw #FrontiersIn #Pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.